Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 57

1.

A Systematic Assessment of the Use of Platelet-Rich Plasma in Spinal Fusion.

Elder BD, Holmes C, Goodwin CR, Lo SF, Puvanesarajah V, Kosztowski TA, Locke JE, Witham TF.

Ann Biomed Eng. 2015 Mar 21. [Epub ahead of print]

PMID:
25794962
2.

A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.

Locke JE, Mehta S, Reed RD, MacLennan P, Massie A, Nellore A, Durand C, Segev DL.

J Am Soc Nephrol. 2015 Mar 19. pii: ASN.2014070726. [Epub ahead of print]

PMID:
25791727
3.

Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients.

Locke JE, Reed RD, Mehta SG, Durand C, Mannon RB, MacLennan P, Shelton B, Martin MY, Qu H, Shewchuk R, Segev DL.

Am J Transplant. 2015 Mar 13. doi: 10.1111/ajt.13220. [Epub ahead of print]

PMID:
25773499
4.

Identification of strategies to facilitate organ donation among African Americans using the nominal group technique.

Locke JE, Qu H, Shewchuk R, Mannon RB, Gaston R, Segev DL, Mannon EC, Martin MY.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):286-93. doi: 10.2215/CJN.05770614. Epub 2015 Jan 29.

PMID:
25635038
5.

The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costs.

DuBay DA, MacLennan PA, Reed RD, Fouad M, Martin M, Meeks CB, Taylor G, Kilgore ML, Tankersley M, Gray SH, White JA, Eckhoff DE, Locke JE.

Am J Transplant. 2015 Feb;15(2):541-6. doi: 10.1111/ajt.12981.

PMID:
25612501
6.

Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation.

Orandi BJ, Zachary AA, Dagher NN, Bagnasco SM, Garonzik-Wang JM, Van Arendonk KJ, Gupta N, Lonze BE, Alachkar N, Kraus ES, Desai NM, Locke JE, Racusen LC, Segev DL, Montgomery RA.

Transplantation. 2014 Oct 27;98(8):857-63. doi: 10.1097/TP.0000000000000298.

PMID:
25121475
7.

To whom goes the kidney?

Locke JE.

Liver Transpl. 2014 Sep;20(9):1017-8. doi: 10.1002/lt.23953. No abstract available.

PMID:
25044428
8.

The authors' reply.

Locke JE, Segev DL.

Transplantation. 2014 Jun 27;97(12):e70-1. doi: 10.1097/TP.0000000000000193. No abstract available.

PMID:
24933253
9.

Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteria.

DuBay DA, Redden DT, Bryant MK, Dorn DP, Fouad MN, Gray SH, White JA, Locke JE, Meeks CB, Taylor GC, Kilgore ML, Eckhoff DE.

Transplantation. 2014 May 27;97(10):1043-8. doi: 10.1097/01.TP.0000441093.32217.cb.

10.

Is there a role for detection of complement-binding antibodies in kidney transplantation?

Locke JE, Segev DL.

Am J Kidney Dis. 2014 Apr;63(4):558-60. doi: 10.1053/j.ajkd.2014.01.007. Epub 2014 Jan 28. No abstract available.

PMID:
24480655
11.

Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients.

Locke JE, James NT, Mannon RB, Mehta SG, Pappas PG, Baddley JW, Desai NM, Montgomery RA, Segev DL.

Transplantation. 2014 Feb 27;97(4):446-50. doi: 10.1097/01.TP.0000436905.54640.8c.

PMID:
24162248
12.

In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression.

Lonze BE, Holzer HT, Knabel MK, Locke JE, DiCamillo GA, Karhadkar SS, Montgomery RA, Sun Z, Warren DS, Cameron AM.

Arch Surg. 2012 Apr;147(4):384-7. doi: 10.1001/archsurg.2011.1250.

PMID:
22508787
13.

Donor-derived organ transplant transmission of coccidioidomycosis.

Dierberg KL, Marr KA, Subramanian A, Nace H, Desai N, Locke JE, Zhang S, Diaz J, Chamberlain C, Neofytos D.

Transpl Infect Dis. 2012 Jun;14(3):300-4. doi: 10.1111/j.1399-3062.2011.00696.x. Epub 2011 Dec 18.

PMID:
22176496
14.

Outcomes of renal transplants from Centers for Disease Control and Prevention high-risk donors with prospective recipient viral testing: a single-center experience.

Lonze BE, Dagher NN, Liu M, Kucirka LM, Simpkins CE, Locke JE, Desai NM, Cameron AM, Montgomery RA, Segev DL, Singer AL.

Arch Surg. 2011 Nov;146(11):1261-6. doi: 10.1001/archsurg.2011.267.

PMID:
22106317
15.

Late graft loss among pediatric recipients of DCD kidneys.

Van Arendonk KJ, James NT, Locke JE, Montgomery RA, Colombani PM, Segev DL.

Clin J Am Soc Nephrol. 2011 Nov;6(11):2705-11. doi: 10.2215/CJN.03760411. Epub 2011 Sep 22.

16.

A novel method of core aspirate cytology compared to fine-needle aspiration for diagnosing canine osteosarcoma.

Neihaus SA, Locke JE, Barger AM, Borst LB, Goring RL.

J Am Anim Hosp Assoc. 2011 Sep-Oct;47(5):317-23. doi: 10.5326/JAAHA-MS-5676. Epub 2011 Aug 18.

PMID:
21852507
17.

Desensitization in HLA-incompatible kidney recipients and survival.

Montgomery RA, Lonze BE, King KE, Kraus ES, Kucirka LM, Locke JE, Warren DS, Simpkins CE, Dagher NN, Singer AL, Zachary AA, Segev DL.

N Engl J Med. 2011 Jul 28;365(4):318-26. doi: 10.1056/NEJMoa1012376.

18.

Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).

Flory AB, Rassnick KM, Erb HN, Garrett LD, Northrup NC, Selting KA, Phillips BS, Locke JE, Chretin JD.

J Am Vet Med Assoc. 2011 Feb 15;238(4):501-6. doi: 10.2460/javma.238.4.501.

PMID:
21320021
19.

Renal Transplantation in HIV-Positive Recipients.

Locke JE, Segev DL.

Curr Infect Dis Rep. 2010 Jan;12(1):71-5. doi: 10.1007/s11908-009-0078-3.

PMID:
21308500
20.

Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.

Locke JE, Singer AL.

Hepat Med. 2011 May 13;3:53-62. doi: 10.2147/HMER.S13682. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk